CD2 costimulation strength: A key regulator of T cell function and anti-tumor immunity that is epigenetically regulated
Philippos Demetriou(Nuffield Orthopaedic Centre), Paul Costeas(Deakin University), Georgia Stavrou(Cancer Research UK), Dimitrios Miltiadis Vrachnos, Άθως Αντωνιάδης(Unknown), Jianxiang Chi(Center for the Study of Childhood and Adolescence), Maria Iakovou(Center for the Study of Childhood and Adolescence), Vasilia Tamamouna(Wellcome/MRC Cambridge Stem Cell Institute), Vakis Papanastasiou(Aretaeio Hospital), Gregoria Gregoriou(Center for the Study of Childhood and Adolescence)
Cited by 0
Related Papers
Molecular and functional characterization of the Salmonella invasion gene invA: homology of InvA to members of a new protein family
|Journal of Bacteriology|1992|586
The EUTOS population-based registry: incidence and clinical characteristics of 2904 CML patients in 20 European Countries
|Leukemia|2015|258
TGF-β inhibition combined with cytotoxic nanomedicine normalizes triple negative breast cancer microenvironment towards anti-tumor immunity
|Theranostics|2020|200